BKYI (BIO-key International, Inc. Common Stock) Stock Analysis - News
BIO-key International, Inc. Common Stock (BKYI) is a publicly traded Industrials sector company. As of May 21, 2026, BKYI trades at $3.46 with a market cap of $5.76M and a P/E ratio of -3.84. BKYI moved -30.51% today. Year to date, BKYI is -41.33%; over the trailing twelve months it is -56.75%. Its 52-week range spans $3.40 to $36.80. Rallies surfaces BKYI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in BKYI news today?
BIO-key Executes 1-for-10 Reverse Split, Nasdaq Suspends Trading; Shares Move to OTC Markets: BIO-key’s Nasdaq trading will be suspended after May 12 close for missing ten consecutive days above $1 bid and fiscal 2025 10-K; shares will trade on OTC Markets starting May 13. The company executed a 1-for-10 reverse split on April 30 and plans to appeal to a Nasdaq hearings panel.
DEPASQUALE MICHAEL W bought 1.62K (~$1.36K) on Sep 16, 2025.
DEPASQUALE MICHAEL W bought 1.62K (~$1.36K) on Sep 16, 2025.
DEPASQUALE MICHAEL W bought 2.50K (~$1.88K) on Sep 15, 2025.
BKYI Analyst Consensus
BKYI analyst coverage data. Average price target: $0.00.
Common questions about BKYI
What changed in BKYI news today?
BIO-key Executes 1-for-10 Reverse Split, Nasdaq Suspends Trading; Shares Move to OTC Markets: BIO-key’s Nasdaq trading will be suspended after May 12 close for missing ten consecutive days above $1 bid and fiscal 2025 10-K; shares will trade on OTC Markets starting May 13. The company executed a 1-for-10 reverse split on April 30 and plans to appeal to a Nasdaq hearings panel.
Does Rallies summarize BKYI news?
Yes. Rallies summarizes BKYI news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is BKYI research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BKYI. It does not provide personalized investment advice.
